Clinical Trials Sponsored by Ingrid Jazet

Total 286 results

Ingrid Jazet

Unknown

Mirabegron and Brown Adipose Tissue (Mirab)

Obesity

Netherlands
Ingrid Jazet
AstraZeneca

Unknown

Exenatide and Brown Adipose Tissue (exe01)

Obesity

Netherlands
Ingrid Jazet
Merck Sharp & Dohme LLC

Completed

Sitagliptin and Brown Adipose Tissue (Sita01)

Neoplasms, Adipose Tissue

Netherlands
Janet Vittone

Completed

Evaluating VR Therapy Using Cold Pressor Test

Pain

United States
Janet Andrews

Active, not recruiting

Incentives and Glucose Adherence in Diabetes

Diabetes in Pregnancy

United States
University Hospital, Lille
JAPET MEDICAL DEVICE

Completed

Alleviating Trunk Low Back Pain, With an Active Medical Device Study (ATLAS) (ATLAS)

Chronic Low Back Pain

France
Ingrid Hopper
HBA

Completed

Screening Evaluation of the Evolution of New Heart Failure (SCREEN-HF)

Heart Failure

Australia
A. Janet Tomiyama

Completed

Implications of Wearing a Fat Suit

Feeding Behaviors
Janet Novotny

Completed

Grape Polyphenol Kinetics in Humans

Healthy Volunteers

United States
Janet Novotny

Completed

The Potential for Pomegranate Juice to Ameliorate Endothelial Dysfunction

Healthy

United States
A. Janet Tomiyama

Completed

Randomized Controlled Experiment of Dieting in Pairs

Dietary Modification
Ingrid Pabinger, MD
GlaxoSmithKline

Completed

Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag (PLATEFUN)

Idiopathic Thrombocytopenic Purpura
Janet Novotny
National Cancer Institute (NCI)

Completed

Blackberry Flavonoid Absorption and Effects on Intestinal Bacteria

Metabolic Syndrome

United States
Sigrid Therapeutics AB

Completed

STAR Study Investigating Performance and Safety of the Medical Device SiPore15™

Overweight | PreDiabetes | Prediabetic State | Type2 Diabetes | Obese | Type2 Diabetes Mellitus | Pre Diabetes

Finland, Sweden
Sigrid Therapeutics AB

Recruiting

Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21® (SHINE)

Overweight or Obesity

Slovakia, Poland, Romania
Inari Medical

Enrolling by invitation

FlowTriever2 Pulmonary Embolectomy Clinical Study (FLARE-FT2)

Pulmonary Embolism

United States
Inari Medical

Completed

FlowTriever Pulmonary Embolectomy Clinical Study (FLARE)

Pulmonary Embolism | Submassive Pulmonary Embolism | Acute Pulmonary Embolism | Massive Pulmonary Embolism

United States
Inari Medical

Recruiting

The PEERLESS II Study

Pulmonary Embolism

United States, Canada, France, Switzerland, Germany, Spain, Poland, Belgium
Inari Medical

Completed

FLowTriever for Acute Massive Pulmonary Embolism (FLAME) (FLAME)

PE - Pulmonary Embolism | PE - Pulmonary Thromboembolism

United States
Inari Medical

Recruiting

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis (DEFIANCE)

Venous Thromboembolism | Deep Venous Thrombosis | Post-Thrombotic Syndrome

United States, Germany, Switzerland
Inari Medical

Active, not recruiting

FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH)

PE - Pulmonary Embolism | PE - Pulmonary Thromboembolism

United States, Spain, Belgium, Germany, France, Switzerland, Netherlands, United Kingdom, Austria
Inari Medical

Active, not recruiting

ClotTriever Outcomes (CLOUT) Registry (CLOUT)

DVT | Deep Vein Thrombosis Leg | Chronic DVT of Lower Extremity | Acute DVT of Lower Extremity

United States
Inari Medical

Active, not recruiting

The PEERLESS Study (PEERLESS)

Pulmonary Embolism | Pulmonary Thrombo-embolism

United States, Germany, Switzerland
Vanderbilt-Ingram Cancer Center

Recruiting

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

Soft Tissue Sarcomas

United States
Vanderbilt-Ingram Cancer Center

Active, not recruiting

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Estrogen Receptor-positive Breast Cancer

United States
Vanderbilt-Ingram Cancer Center

Active, not recruiting

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

Polycythemia Vera | Myelofibrosis

United States
Vanderbilt-Ingram Cancer Center

Active, not recruiting

High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients

Hematopoietic Cell Transplantation

United States
Vanderbilt-Ingram Cancer Center

Completed

A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma

Malignant Glioma

United States
Vanderbilt-Ingram Cancer Center

Terminated

Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy Infusion

Malignant Neoplasm

United States
Vanderbilt-Ingram Cancer Center

Terminated

PET/CT Evaluation of Treatment Response in Breast Cancer

Breast Cancer

United States
Vanderbilt-Ingram Cancer Center

Completed

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer (68Ga)

Neuroendocrine Carcinoma

United States
Vanderbilt-Ingram Cancer Center

Withdrawn

MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer

Metastatic Breast Cancer
Vanderbilt-Ingram Cancer Center

Completed

Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients

Adult Stem Cell Hematopoetic Transplant

United States
Vanderbilt-Ingram Cancer Center

Recruiting

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Metastatic Digestive System Neuroendocrine Neoplasm | Metastatic Malignant Neoplasm in the Liver | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Digestive System Neuroendocrine Tumor G1 | Digestive System Neuroendocrine Tumor G2

United States
Vanderbilt-Ingram Cancer Center

Recruiting

Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 Inhibitors

Metastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Refractory Melanoma

United States
Vanderbilt-Ingram Cancer Center

Recruiting

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

Diabetes Mellitus | Cancer

United States
Vanderbilt-Ingram Cancer Center

Recruiting

Inherited CAncer REgistry (ICARE)

Cancer

United States
Vanderbilt-Ingram Cancer Center

Recruiting

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Melanoma

United States
Vanderbilt-Ingram Cancer Center

Active, not recruiting

COVID-19 and Cancer Consortium Registry (CCC19)

COVID-19 | Invasive Malignancy (Any Type)

United States
Vanderbilt-Ingram Cancer Center

Completed

PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Vanderbilt-Ingram Cancer Center

Completed

PET Study in Patients With Non-Hodgkin Lymphoma

Lymphoma

United States
Vanderbilt-Ingram Cancer Center

Terminated

Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer

Hormone-sensitive Metastatic Breast Cancer

United States
Vanderbilt-Ingram Cancer Center

Not yet recruiting

TBNA vs EBUS-TBNA Plus Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing (META-Gen)

Lung Cancer

United States
Vanderbilt-Ingram Cancer Center

Terminated

Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System

Thyroid Carcinoma | Radioactive Iodine Level

United States
Vanderbilt-Ingram Cancer Center

Active, not recruiting

Non-Myeloablative Conditioning and Bone Marrow Transplantation

Sickle Cell Disease | Hemoglobinopathies

United States, United Kingdom, France
Vanderbilt-Ingram Cancer Center

Completed

First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade

Multiple Myeloma

United States
Vanderbilt-Ingram Cancer Center

Withdrawn

Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads

Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center

Completed

Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer

Rectal Cancer

United States
Vanderbilt-Ingram Cancer Center

Terminated

Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer

Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal Cancer

United States
Vanderbilt-Ingram Cancer Center

Withdrawn

Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer

Metastatic Breast Cancer

Clinical Trials Sponsored by Ingrid Jazet

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations